Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 6 | 2020 | 182 | 1.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2020 | 1477 | 0.850 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 424 | 0.770 |
Why?
|
| Hypoglycemic Agents | 8 | 2017 | 183 | 0.700 |
Why?
|
| Risk Assessment | 8 | 2020 | 1469 | 0.660 |
Why?
|
| Chest Pain | 5 | 2020 | 223 | 0.660 |
Why?
|
| Psoas Muscles | 1 | 2019 | 19 | 0.600 |
Why?
|
| Mass Screening | 2 | 2020 | 268 | 0.580 |
Why?
|
| Sarcopenia | 1 | 2019 | 66 | 0.560 |
Why?
|
| Aged | 31 | 2020 | 10637 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 950 | 0.510 |
Why?
|
| Male | 39 | 2020 | 19754 | 0.500 |
Why?
|
| United States | 16 | 2020 | 4132 | 0.490 |
Why?
|
| Female | 36 | 2020 | 20375 | 0.470 |
Why?
|
| Humans | 48 | 2020 | 32968 | 0.460 |
Why?
|
| Middle Aged | 31 | 2020 | 12203 | 0.440 |
Why?
|
| Adult | 23 | 2020 | 9586 | 0.430 |
Why?
|
| Models, Statistical | 3 | 2014 | 180 | 0.420 |
Why?
|
| Proportional Hazards Models | 10 | 2019 | 765 | 0.420 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 894 | 0.410 |
Why?
|
| Online Systems | 1 | 2014 | 12 | 0.410 |
Why?
|
| Forecasting | 1 | 2014 | 143 | 0.400 |
Why?
|
| Acute Coronary Syndrome | 3 | 2020 | 204 | 0.400 |
Why?
|
| Diabetic Angiopathies | 3 | 2017 | 145 | 0.390 |
Why?
|
| Mortality | 3 | 2020 | 125 | 0.380 |
Why?
|
| Patient Readmission | 3 | 2019 | 135 | 0.380 |
Why?
|
| Cardiovascular Diseases | 3 | 2005 | 1152 | 0.380 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 222 | 0.350 |
Why?
|
| Cohort Studies | 8 | 2019 | 1852 | 0.340 |
Why?
|
| Point-of-Care Systems | 2 | 2017 | 46 | 0.330 |
Why?
|
| Hospitalization | 4 | 2020 | 495 | 0.320 |
Why?
|
| Neoplasms | 5 | 2013 | 762 | 0.320 |
Why?
|
| Risk Factors | 17 | 2019 | 4001 | 0.310 |
Why?
|
| Cholesterol | 3 | 2005 | 255 | 0.310 |
Why?
|
| C-Reactive Protein | 3 | 2005 | 240 | 0.310 |
Why?
|
| Health Care Costs | 1 | 2009 | 122 | 0.280 |
Why?
|
| Metformin | 4 | 2016 | 25 | 0.280 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 487 | 0.280 |
Why?
|
| Iron | 2 | 2005 | 116 | 0.270 |
Why?
|
| Medicare | 2 | 2019 | 213 | 0.270 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 166 | 0.270 |
Why?
|
| Transferrin | 2 | 2005 | 33 | 0.270 |
Why?
|
| Cholesterol, LDL | 2 | 2004 | 173 | 0.250 |
Why?
|
| Medical Records | 2 | 2003 | 77 | 0.240 |
Why?
|
| Patient Discharge | 3 | 2019 | 205 | 0.240 |
Why?
|
| Algorithms | 4 | 2020 | 517 | 0.230 |
Why?
|
| Odds Ratio | 6 | 2020 | 467 | 0.230 |
Why?
|
| Hypothyroidism | 1 | 2005 | 12 | 0.230 |
Why?
|
| Troponin | 3 | 2020 | 112 | 0.230 |
Why?
|
| Arginine | 1 | 2005 | 18 | 0.220 |
Why?
|
| Autoantibodies | 1 | 2005 | 49 | 0.220 |
Why?
|
| Chlamydophila Infections | 1 | 2004 | 2 | 0.220 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2004 | 3 | 0.220 |
Why?
|
| Macrolides | 1 | 2004 | 5 | 0.220 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 47 | 0.220 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 105 | 0.200 |
Why?
|
| Dementia | 2 | 2005 | 247 | 0.200 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 37 | 0.200 |
Why?
|
| Nomograms | 3 | 2014 | 35 | 0.200 |
Why?
|
| Resuscitation Orders | 1 | 2003 | 13 | 0.200 |
Why?
|
| Drug Combinations | 1 | 2003 | 99 | 0.200 |
Why?
|
| Religion and Medicine | 1 | 2003 | 19 | 0.190 |
Why?
|
| Young Adult | 5 | 2020 | 2738 | 0.190 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 10 | 0.190 |
Why?
|
| Physician's Role | 1 | 2003 | 39 | 0.190 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 18 | 0.190 |
Why?
|
| Enteral Nutrition | 1 | 2002 | 28 | 0.190 |
Why?
|
| Retrospective Studies | 11 | 2017 | 3708 | 0.190 |
Why?
|
| Time Factors | 5 | 2019 | 2195 | 0.180 |
Why?
|
| Sex Factors | 4 | 2020 | 684 | 0.180 |
Why?
|
| Comorbidity | 5 | 2017 | 573 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 332 | 0.180 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 476 | 0.180 |
Why?
|
| Logistic Models | 6 | 2020 | 783 | 0.180 |
Why?
|
| Prognosis | 4 | 2019 | 1547 | 0.170 |
Why?
|
| Age of Onset | 1 | 2020 | 92 | 0.160 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 16 | 0.150 |
Why?
|
| Holidays | 1 | 2019 | 4 | 0.150 |
Why?
|
| Models, Biological | 2 | 2012 | 392 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2017 | 909 | 0.150 |
Why?
|
| Eggs | 1 | 2018 | 4 | 0.150 |
Why?
|
| Meat | 1 | 2018 | 17 | 0.150 |
Why?
|
| Internal Medicine | 1 | 2019 | 55 | 0.150 |
Why?
|
| Organ Size | 1 | 2019 | 220 | 0.140 |
Why?
|
| Survival Analysis | 4 | 2019 | 486 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 265 | 0.140 |
Why?
|
| Age Factors | 3 | 2019 | 1202 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 73 | 0.140 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 4065 | 0.140 |
Why?
|
| Ethnic Groups | 1 | 2020 | 474 | 0.140 |
Why?
|
| Glycemic Index | 1 | 2017 | 14 | 0.140 |
Why?
|
| Heart Failure | 3 | 2017 | 761 | 0.140 |
Why?
|
| Hip Fractures | 1 | 2017 | 30 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 175 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2018 | 158 | 0.130 |
Why?
|
| Pneumonia | 1 | 2017 | 64 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2017 | 78 | 0.130 |
Why?
|
| Nutrition Surveys | 4 | 2005 | 151 | 0.130 |
Why?
|
| Oximetry | 1 | 2016 | 31 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2017 | 183 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 44 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2016 | 30 | 0.120 |
Why?
|
| Diet | 1 | 2018 | 393 | 0.120 |
Why?
|
| Risk | 4 | 2015 | 316 | 0.120 |
Why?
|
| Emergency Service, Hospital | 4 | 2020 | 499 | 0.120 |
Why?
|
| Oxygen | 1 | 2016 | 144 | 0.120 |
Why?
|
| Sulfonylurea Compounds | 5 | 2015 | 8 | 0.120 |
Why?
|
| Smoking | 4 | 2009 | 531 | 0.120 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 416 | 0.110 |
Why?
|
| Social Class | 1 | 2015 | 93 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 136 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 110 | 0.110 |
Why?
|
| Adolescent | 2 | 2020 | 3643 | 0.110 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 134 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 883 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 21 | 0.110 |
Why?
|
| Hematologic Tests | 1 | 2014 | 12 | 0.110 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 60 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 178 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2012 | 369 | 0.100 |
Why?
|
| Decision Making | 1 | 2015 | 203 | 0.100 |
Why?
|
| Continental Population Groups | 1 | 2014 | 236 | 0.090 |
Why?
|
| Albuminuria | 1 | 2013 | 180 | 0.090 |
Why?
|
| Computational Biology | 1 | 2012 | 96 | 0.090 |
Why?
|
| Stroke | 1 | 2017 | 610 | 0.090 |
Why?
|
| Energy Intake | 2 | 2018 | 128 | 0.090 |
Why?
|
| North Carolina | 3 | 2020 | 1550 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2011 | 27 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1179 | 0.080 |
Why?
|
| Testicular Neoplasms | 1 | 2009 | 15 | 0.080 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 11 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1310 | 0.080 |
Why?
|
| Unemployment | 1 | 2009 | 4 | 0.080 |
Why?
|
| Incidence | 3 | 2013 | 1246 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2020 | 2338 | 0.080 |
Why?
|
| Efficiency | 1 | 2009 | 18 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 21 | 0.080 |
Why?
|
| ROC Curve | 3 | 2017 | 169 | 0.080 |
Why?
|
| Employment | 1 | 2009 | 51 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 72 | 0.070 |
Why?
|
| Health Surveys | 1 | 2009 | 200 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 51 | 0.070 |
Why?
|
| Software | 1 | 2009 | 128 | 0.070 |
Why?
|
| Thiazolidinediones | 3 | 2015 | 45 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 98 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2009 | 91 | 0.070 |
Why?
|
| Length of Stay | 1 | 2009 | 329 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2009 | 217 | 0.070 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 162 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2017 | 34 | 0.070 |
Why?
|
| African Americans | 2 | 2020 | 1425 | 0.070 |
Why?
|
| Triglycerides | 2 | 2005 | 229 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2007 | 45 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2008 | 880 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 780 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 149 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 2287 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 682 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 1002 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3460 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Thyroglobulin | 1 | 2005 | 2 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2005 | 4 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 46 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2005 | 7 | 0.060 |
Why?
|
| Thyroxine | 1 | 2005 | 16 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 24 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2005 | 20 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 80 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2020 | 637 | 0.060 |
Why?
|
| Mental Recall | 1 | 2005 | 51 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2005 | 148 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 269 | 0.050 |
Why?
|
| Lipids | 1 | 2005 | 230 | 0.050 |
Why?
|
| Ferritins | 1 | 2004 | 48 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 178 | 0.050 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2003 | 1 | 0.050 |
Why?
|
| Nutrition Disorders | 1 | 2002 | 12 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 254 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2002 | 8 | 0.050 |
Why?
|
| Registries | 2 | 2015 | 320 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2002 | 16 | 0.050 |
Why?
|
| Canada | 1 | 2002 | 64 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2003 | 147 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2002 | 55 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 541 | 0.050 |
Why?
|
| Glipizide | 2 | 2012 | 2 | 0.040 |
Why?
|
| Glyburide | 2 | 2012 | 4 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 302 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 262 | 0.040 |
Why?
|
| Exercise | 1 | 2005 | 688 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 770 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 576 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2018 | 55 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 527 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2019 | 221 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 99 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 50 | 0.030 |
Why?
|
| Quality of Life | 1 | 2002 | 976 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2016 | 6 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 17 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Goals | 1 | 2016 | 35 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 156 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 81 | 0.030 |
Why?
|
| Radiculopathy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 13 | 0.030 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 495 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 288 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 80 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2015 | 51 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2020 | 930 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 290 | 0.030 |
Why?
|
| Biguanides | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 64 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 54 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1581 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 895 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 410 | 0.020 |
Why?
|
| Propensity Score | 1 | 2012 | 48 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 154 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 360 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 220 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 319 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 92 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 983 | 0.020 |
Why?
|
| Child | 1 | 2016 | 2478 | 0.020 |
Why?
|
| Ileostomy | 1 | 2009 | 8 | 0.020 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2009 | 17 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2009 | 12 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 30 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 95 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 594 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 212 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 471 | 0.020 |
Why?
|
| Reoperation | 1 | 2009 | 260 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 111 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 384 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 197 | 0.020 |
Why?
|
| Survivors | 1 | 2009 | 168 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 14 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 80 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 512 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 754 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 566 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 185 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 201 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 32 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 599 | 0.010 |
Why?
|